A detailed history of High Tower Advisors, LLC transactions in Immuneering Corp stock. As of the latest transaction made, High Tower Advisors, LLC holds 43,960 shares of IMRX stock, worth $84,403. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,960
Holding current value
$84,403
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.28 - $2.75 $56,268 - $120,890
43,960 New
43,960 $56,000
Q3 2023

Nov 08, 2023

BUY
$7.21 - $10.68 $172,751 - $255,892
23,960 New
23,960 $184,000

Others Institutions Holding IMRX

About Immuneering Corp


  • Ticker IMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,392,300
  • Market Cap $50.7M
  • Description
  • Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...
More about IMRX
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.